All stock lists
SOPHiA GENETICS SA (NASDAQ:SOPH)
CH · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
7.46+0.11 (+1.50%)
Insider Score
––Not scored
SOPH Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SOPH Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 23.31 M | 21.69 M | 21.71 M | 19.46 M | 18.32 M | 17.78 M |
| Revenue Growth (YoY) | 27.22 % | 21.99 % | 22.41 % | 22.77 % | 15.91 % | 12.68 % |
| Cost of Revenue | 8.25 M | 6.94 M | 7.01 M | 6.55 M | 6.05 M | 5.57 M |
| Gross Profit | 15.06 M | 14.75 M | 14.69 M | 12.91 M | 12.27 M | 12.21 M |
| SG&A Expense | 26.39 M | 22.57 M | 24.20 M | 22.56 M | 22.34 M | 19.13 M |
| R&D Expense | 8.73 M | 11.06 M | 8.54 M | 9.40 M | 8.49 M | 9.12 M |
| Operating Expenses | 35.11 M | 32.03 M | 32.74 M | 30.77 M | 30.83 M | 28.24 M |
| Operating Income | -20.05 M | -17.28 M | -18.05 M | -17.86 M | -18.56 M | -16.04 M |
| Pretax Income | -22.28 M | -19.07 M | -19.57 M | -19.38 M | -21.65 M | -16.88 M |
| Tax Provision | 78.00 K | 253.00 K | -395.00 K | 642.00 K | 762.00 K | 503.00 K |
| Net Income | -22.36 M | -19.32 M | -19.18 M | -20.02 M | -22.41 M | -17.39 M |
| EPS (Basic) | -0.30 | -0.27 | -0.28 | -0.30 | -0.33 | -0.26 |
| EPS (Diluted) | -0.30 | -0.27 | -0.28 | -0.30 | -0.33 | -0.26 |
| Shares Outstanding | 73.84 M | 71.14 M | 68.24 M | 67.79 M | 67.32 M | 66.84 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.